We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+17%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.33B
AUM Growth
+$1.78B
Cap. Flow
+$552M
Cap. Flow %
5.91%
Top 10 Hldgs %
20.52%
Holding
814
New
78
Increased
378
Reduced
271
Closed
33

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$50.3M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$39.4M
3
INTC icon
Intel
INTC
+$29.2M
4
QCOM icon
Qualcomm
QCOM
+$27.6M
5
DHR icon
Danaher
DHR
+$26M

Top Sells

Rank Stock Value
1
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$49.9M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$41.6M
3
ARQL
Arqule Inc
ARQL
+$26.5M
4
ARWR icon
Arrowhead Research
ARWR
+$24.9M
5
MRK icon
Merck
MRK
+$15.4M

Sector Composition

Rank Sector Weight
1 Healthcare 30.73%
2 Technology 19.55%
3 Financials 10.18%
4 Consumer Discretionary 9.32%
5 Communication Services 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MET icon
101
MetLife
MET
$61B
$20.2M 0.22%
395,846
+59,399
+18% +$2.87M
NBIX icon
102
Neurocrine Biosciences
NBIX
$17.7B
$20.1M 0.22%
186,766
-17,903
-9% -$1.87M
PTC icon
103
PTC
PTC
$13.7B
$19.9M 0.21%
266,287
-34,866
-12% -$2.48M
PFE icon
104
Pfizer
PFE
$140B
$19.9M 0.21%
536,298
+205,759
+62% +$7.33M
LH icon
105
Labcorp
LH
$24.3B
$19.8M 0.21%
135,924
+13,986
+11% +$2.02M
KMB icon
106
Kimberly-Clark
KMB
$36.4B
$19.6M 0.21%
142,431
+54,238
+61% +$7.34M
VAR
107
DELISTED
Varian Medical Systems, Inc.
VAR
$19.4M 0.21%
136,441
+66,405
+95% +$8.47M
DRNA
108
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$19.4M 0.21%
879,500
+160,000
+22% +$3.22M
DG icon
109
Dollar General
DG
$25.9B
$19.3M 0.21%
123,597
+8,526
+7% +$1.35M
NEE icon
110
NextEra Energy
NEE
$187B
$19.1M 0.2%
315,212
+27,248
+9% +$1.59M
IBM icon
111
IBM
IBM
$202B
$19M 0.2%
148,269
+18,009
+14% +$2.34M
KEYS icon
112
Keysight
KEYS
$54.5B
$18.8M 0.2%
182,805
-78,092
-30% -$7.99M
TIF
113
DELISTED
Tiffany & Co.
TIF
$18.8M 0.2%
140,300
+57,426
+69% +$6.79M
HES
114
DELISTED
Hess
HES
$18.6M 0.2%
278,363
+109,965
+65% +$7.19M
HOLX
115
DELISTED
Hologic
HOLX
$18.5M 0.2%
355,160
+139,296
+65% +$6.94M
INTU icon
116
Intuit
INTU
$81.1B
$18.4M 0.2%
70,213
+6,056
+9% +$1.58M
BAC icon
117
Bank of America
BAC
$435B
$18.4M 0.2%
521,649
+48,176
+10% +$1.56M
ARNA
118
DELISTED
Arena Pharmaceuticals Inc
ARNA
$18M 0.19%
396,800
+31,000
+8% +$1.47M
WBC
119
DELISTED
WABCO HOLDINGS INC.
WBC
$18M 0.19%
132,954
-24,351
-15% -$3.28M
BKNG icon
120
Booking.com
BKNG
$138B
$18M 0.19%
219,125
+10,000
+5% +$785K
ARWR icon
121
Arrowhead Research
ARWR
$12.1B
$17.9M 0.19%
282,508
-501,492
-64% -$24.9M
DFS
122
DELISTED
Discover Financial Services
DFS
$17.6M 0.19%
207,481
+33,202
+19% +$2.74M
CIB icon
123
Grupo Cibest SA
CIB
$20.4B
$17.6M 0.19%
320,904
-21,685
-6% -$1.12M
TAL icon
124
TAL Education Group
TAL
$5.71B
$17.5M 0.19%
362,477
-93,268
-20% -$4.01M
AMD icon
125
Advanced Micro Devices
AMD
$851B
$17.5M 0.19%
380,558
-112,372
-23% -$4.14M
3 4
5
6 7

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2019 Portfolio in Review

As of Q4 2019, Candriam SCA held 814 positions worth $9.33B, up 24% from $7.55B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA deployed $552M of net new capital in Q4 2019, opening 78 new positions and adding to 378 existing holdings. Its largest new stake was Vipshop: 2,005,000 shares worth $28.4M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Ra Pharmaceuticals, Inc. Common Stock, an estimated $49.9M trimmed.

  • Candriam SCA's largest Q4 2019 buy was Vipshop: 2,005,000 shares worth $28.4M.
  • Candriam SCA added most to Microsoft in Q4 2019, an estimated $50.3M increase.
  • Candriam SCA's biggest Q4 2019 reduction was Ra Pharmaceuticals, Inc. Common Stock, cutting an estimated $49.9M.
  • Candriam SCA fully exited Hilton Worldwide in Q4 2019, selling an estimated $11.8M.
  • Candriam SCA's ten largest holdings make up 21% of its $9.33B portfolio in Q4 2019.
  • Candriam SCA opened 78 new positions and closed 33 in Q4 2019.
  • Candriam SCA's portfolio value rose 24% quarter-over-quarter to $9.33B.

Based on Candriam SCA's 13F filing for Q4 2019, filed 21 Jan 2020.